Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : New Brunswick Scientific Co., Inc. (NBSC) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (308)	10/28/2001 8:28:26 PM
From: Miljenko Zuanic	Read Replies (1) \| Respond to of 724

Rick, Not going into details and long explanation of their business, what percentage of the sales growth are you projecting for next one-two years? Based on current environment: expansion of bio-drugs and shortage of the pilot- and full-scale manufacturing equipment/capacity, fear of the bio-terrorism and biology based warfare, and general expansion in the pharmaceutical capital investment. Also, based on product sale margin and overall expense of doing business, at what point (total annual sale) you are expecting net profit and how will this profit growth? Thank, Miljenko Year Sales Net Income EPS 12/96 42.93 0.88 0.14 12/97 45.60 1.01 0.16 12/98 46.97 -0.16 -0.02 12/99 54.87 -1.15 -0.18 12/00 49.86 -3.93 -0.59